Pediatric Blood & Cancer

Cover image for Pediatric Blood & Cancer

September 2013

Volume 60, Issue 9

Pages 1393–1560, E70–E112

  1. Highlights

    1. Top of page
    2. Highlights
    3. Reviews
    4. Priority Report
    5. Research Articles
    6. Letters To The Editor
    7. Abstracts
    8. Brief Reports
  2. Reviews

    1. Top of page
    2. Highlights
    3. Reviews
    4. Priority Report
    5. Research Articles
    6. Letters To The Editor
    7. Abstracts
    8. Brief Reports
    1. Challenges with defining response to antitumor agents in pediatric neuro-oncology: A report from the response assessment in pediatric neuro-oncology (RAPNO) working group (pages 1397–1401)

      Katherine E. Warren, Tina Y. Poussaint, Gilbert Vezina, Darren Hargrave, Roger J. Packer, Stewart Goldman, Patrick Y. Wen, Ian F. Pollack, David Zurakowski, Larry E. Kun, Michael D. Prados, Stefan Rutkowski and Mark W. Kieran

      Article first published online: 26 APR 2013 | DOI: 10.1002/pbc.24562

    2. You have free access to this content
      Warfarin pharmacogenomics in children (pages 1402–1407)

      Susan I. Vear, C. Michael Stein and Richard H. Ho

      Article first published online: 16 MAY 2013 | DOI: 10.1002/pbc.24592

  3. Priority Report

    1. Top of page
    2. Highlights
    3. Reviews
    4. Priority Report
    5. Research Articles
    6. Letters To The Editor
    7. Abstracts
    8. Brief Reports
    1. You have free access to this content
      Implications of Tumor Location on Subtypes of Medulloblastoma (pages 1408–1410)

      Wan-Yee Teo, Jianhe Shen, Jack Meng Fen Su, Alexander Yu, Jian Wang, Wing-Yuk Chow, Xiaonan Li, Jeremy Jones, Robert Dauser, William Whitehead, Adekunle M. Adesina, Murali Chintagumpala, Tsz-Kwong Man and Ching C. Lau

      Article first published online: 19 MAR 2013 | DOI: 10.1002/pbc.24511

  4. Research Articles

    1. Top of page
    2. Highlights
    3. Reviews
    4. Priority Report
    5. Research Articles
    6. Letters To The Editor
    7. Abstracts
    8. Brief Reports
    1. Oncology

      PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: A children's oncology group report (pages 1411–1417)

      Stephen X. Skapek, James Anderson, Frederic G. Barr, Julia A. Bridge, Julie M. Gastier-Foster, David M. Parham, Erin R. Rudzinski, Timothy Triche and Douglas S. Hawkins

      Article first published online: 22 MAR 2013 | DOI: 10.1002/pbc.24532

    2. Acute changes in blood pressure in patients with neuroblastoma treated with 131I-metaiodobenzylguanidine (MIBG) (pages 1424–1430)

      Thalia Wong, Katherine K. Matthay, W. John Boscardin, Randall A. Hawkins, Paul R. Brakeman and Steven G. DuBois

      Article first published online: 23 APR 2013 | DOI: 10.1002/pbc.24551

    3. Acute toxicity of proton beam radiation for pediatric central nervous system malignancies (pages 1431–1436)

      Gita Suneja, Philip D. Poorvu, Christine Hill-Kayser and Robert A. Lustig

      Article first published online: 22 APR 2013 | DOI: 10.1002/pbc.24554

    4. A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: A children's oncology group phase 1 consortium study (pages 1452–1457)

      Trent R. Hummel, Lars Wagner, Charlotte Ahern, Maryam Fouladi, Joel M. Reid, Renee M. McGovern, Matthew M. Ames, Richard J. Gilbertson, Terzah Horton, Ashish M. Ingle, Brenda Weigel and Susan M. Blaney

      Article first published online: 28 MAR 2013 | DOI: 10.1002/pbc.24541

    5. Relapse after treatment of pediatric hodgkin lymphoma: Outcome and role of surveillance after end of therapy (pages 1458–1463)

      Alison M. Friedmann, Julie A. Wolfson, Melissa M. Hudson, Howard J. Weinstein, Michael P. Link, Amy Billett, Eric C. Larsen, Torunn Yock, Sarah S. Donaldson, Karen Marcus, Matthew J. Krasin, Scott C. Howard and Monika L. Metzger

      Article first published online: 15 MAY 2013 | DOI: 10.1002/pbc.24568

    6. Improving the prognosis of pediatric hodgkin lymphoma in developing countries: A moroccan society of pediatric hematology and oncology study (pages 1464–1469)

      Laila Hessissen, Rachida Khtar, Abdellah Madani, Maria El Kababri, Amina Kili, Mhamed Harif, Mohamed Khattab, Souha Sahraoui, Nouredine Benjaafar, Samir Ahid, Scott C. Howard and Said Benchekroun

      Article first published online: 20 APR 2013 | DOI: 10.1002/pbc.24534

    7. Mental health disparities between hispanic and non-hispanic parents of childhood cancer survivors (pages 1470–1477)

      Kathleen A. Meeske, Sandra Sherman-Bien, Ann S. Hamilton, Anamara Ritt Olson, Rhona Slaughter, Aura Kuperberg and Joel Milam

      Article first published online: 19 MAR 2013 | DOI: 10.1002/pbc.24527

    8. Long-term outcome of vincristine–aspirin–ticlopidine (VAT) therapy for vascular tumors associated with kasabach–merritt phenomenon (pages 1478–1481)

      Israel Fernandez-Pineda, Juan Carlos Lopez-Gutierrez, Gloria Chocarro, Jose Bernabeu-Wittel and Gema Lucia Ramirez-Villar

      Article first published online: 22 APR 2013 | DOI: 10.1002/pbc.24543

    9. Hematology

    10. Alloimmunization in sickle cell anemia in the era of extended red cell typing (pages 1487–1491)

      Chibuzo O'Suoji, Robert I. Liem, A. Kyle Mack, Paris Kingsberry, Glenn Ramsey and Alexis. A. Thompson

      Article first published online: 18 MAR 2013 | DOI: 10.1002/pbc.24530

    11. Acute care of pediatric patients with sickle cell disease: A simulation performance assessment (pages 1492–1498)

      Tracy L. Burns, Michael R. DeBaun, John R. Boulet, Gayle M. Murray, David J. Murray and James J. Fehr

      Article first published online: 30 APR 2013 | DOI: 10.1002/pbc.24558

    12. Transcranial doppler velocity and brain MRI/MRA changes in children with sickle cell anemia on chronic transfusions to prevent primary stroke (pages 1499–1502)

      Vivien A. Sheehan, Eileen N. Hansbury, Matthew P. Smeltzer, Gail Fortner, M. Beth McCarville and Banu Aygun

      Article first published online: 26 APR 2013 | DOI: 10.1002/pbc.24569

    13. The palatability and tolerability of deferasirox taken with different beverages or foods (pages 1507–1512)

      Stuart L. Goldberg, Patricia J. Giardina, Deborah Chirnomas, Jason Esposito, Carole Paley and Elliott Vichinsky

      Article first published online: 23 APR 2013 | DOI: 10.1002/pbc.24561

    14. BMT

      PBSCT is associated with poorer survival and increased chronic GvHD than BMT in Japanese paediatric patients with acute leukaemia and an HLA-matched sibling donor (pages 1513–1519)

      Aki Shinzato, Ken Tabuchi, Yoshiko Atsuta, Masami Inoue, Jiro Inagaki, Hiromasa Yabe, Katsuyoshi Koh, Koji Kato, Hideaki Ohta, Hisato Kigasawa, Toshiyuki Kitoh, Atsushi Ogawa, Yoshiyuki Takahashi, Yoji Sasahara, Shun-Ichi Kato and Souichi Adachi

      Article first published online: 19 MAR 2013 | DOI: 10.1002/pbc.24524

    15. You have full text access to this OnlineOpen article
      Transplant-related mortality following allogeneic hematopoeitic stem cell transplantation for pediatric acute lymphoblastic leukemia: 25-year retrospective review (pages 1520–1527)

      Marion K. Mateos, Tracey A. O'Brien, Cecilia Oswald, Melissa Gabriel, David S. Ziegler, Richard J. Cohn, Susan J. Russell, Draga Barbaric, Glenn M. Marshall and Toby N. Trahair

      Article first published online: 3 JUN 2013 | DOI: 10.1002/pbc.24559

    16. Survivorship

      Early Cardiac Outcomes Following Contemporary Treatment for Childhood Acute Myeloid Leukemia: A North American Perspective (pages 1528–1533)

      Etan Orgel, Laura Zung, Lingyun Ji, Jerry Finklestein, James Feusner and David R. Freyer

      Article first published online: 25 FEB 2013 | DOI: 10.1002/pbc.24498

    17. Endothelial function in long-term survivors of childhood acute lymphoblastic leukemia: Effects of a home-based exercise program (pages 1546–1551)

      Liisa S. Järvelä, Harri Niinikoski, Olli J. Heinonen, Päivi M. Lähteenmäki, Mikko Arola and Jukka Kemppainen

      Article first published online: 20 APR 2013 | DOI: 10.1002/pbc.24565

  5. Letters To The Editor

    1. Top of page
    2. Highlights
    3. Reviews
    4. Priority Report
    5. Research Articles
    6. Letters To The Editor
    7. Abstracts
    8. Brief Reports
    1. Limited renal prophylaxis in regular plasmatherapy for heritable ADAMTS13 deficiency (pages 1557–1558)

      Takehiko Doi, Shouichi Ohga, Naoko Ito, Masataka Ishimura, Naohiro Suga, Akihiko Nomura, Hidetoshi Takada, Masanori Matsumoto, Yoshihiro Fujimura and Toshiro Hara

      Article first published online: 29 APR 2013 | DOI: 10.1002/pbc.24553

    2. Novel frameshift mutations in ADAMTS13 in two families with hereditary thrombotic thrombocytopenic purpura (pages 1559–1560)

      Abdulrahman Alsultan, Mohammed Jarrar, Talal Al-Harbi and Mohammed AL Balwi

      Article first published online: 16 MAY 2013 | DOI: 10.1002/pbc.24594

  6. Abstracts

    1. Top of page
    2. Highlights
    3. Reviews
    4. Priority Report
    5. Research Articles
    6. Letters To The Editor
    7. Abstracts
    8. Brief Reports
  7. Brief Reports

    1. Top of page
    2. Highlights
    3. Reviews
    4. Priority Report
    5. Research Articles
    6. Letters To The Editor
    7. Abstracts
    8. Brief Reports
    1. Frequent mutations in SH2D1A (XLP) in males presenting with high-grade mature B-cell neoplasms (pages E85–E87)

      J.T. Sandlund, S.A. Shurtleff, M. Onciu, E. Horwitz, W. Leung, V. Howard, R. Rencher and M.E. Conley

      Article first published online: 15 APR 2013 | DOI: 10.1002/pbc.24525

    2. Schimke immunoosseous dysplasia associated with undifferentiated carcinoma and a novel SMARCAL1 mutation in a child (pages E88–E90)

      Clinton Carroll, Akosua Badu-Nkansah, Tracy Hunley, Alireza Baradaran-Heravi, David Cortez and Haydar Frangoul

      Article first published online: 29 APR 2013 | DOI: 10.1002/pbc.24542

    3. Absence of epstein–barr and cytomegalovirus infection in neuroblastoma cells by standard detection methodologies (pages E91–E93)

      Daniel Sehic, Ola Forslund, Emma Sandén, Linda Holmquist Mengelbier, Jenny Karlsson, Davit Bzhalava, Johanna Ekström, Janina Warenholt, Anna Darabi, Joakim Dillner, Ingrid Øra and David Gisselsson

      Article first published online: 9 APR 2013 | DOI: 10.1002/pbc.24535

    4. Congenital amegakaryocytic thrombocytopenia (CAMT) presenting as severe pancytopenia in the first month of life (pages E94–E96)

      Michael T. Stoddart, Philip Connor, Manuela Germeshausen, Matthias Ballmaier and Colin G. Steward

      Article first published online: 26 APR 2013 | DOI: 10.1002/pbc.24566

    5. High burden of metastases and poor outcome in pelvic PNET (pages E97–E99)

      Bivas Biswas, Sandeep Agarwala, Shishir Rastogi, Shah Alam Khan, B.K. Mohanti, D.N. Sharma, Sushmita Pathy and Sameer Bakhshi

      Article first published online: 26 APR 2013 | DOI: 10.1002/pbc.24552

    6. Feasibility of dasatinib in children and adolescents with new or recurrent central nervous system germinoma (pages E100–E102)

      Diana S. Osorio, Jonathan L. Finlay, Girish Dhall, Stewart Goldman, David Eisenstat and Robert J. Brown

      Article first published online: 10 JUN 2013 | DOI: 10.1002/pbc.24567

    7. Successful port-a-cath salvage using linezolid in children with acute leukemia (pages E103–E105)

      Rubén B. Moreno, Susana Rives, Antonio Justicia, Albert Català, Anna Ruiz-Llobet, Teresa Toll and Jesús Estella

      Article first published online: 15 JUN 2013 | DOI: 10.1002/pbc.24520

    8. RHD zygosity predicts degree of platelet response to anti-D immune globulin treatment in children with immune thrombocytopenia (pages E106–E108)

      Jenny M. Despotovic, Patrick T. McGann, Matthew Smeltzer, Banu Aygun and Russell E. Ware

      Article first published online: 27 MAY 2013 | DOI: 10.1002/pbc.24574

SEARCH

SEARCH BY CITATION